Share
Back to top
Respiratory syncytial virus (RSV)
-
Respiratory syncytial virus (RSV) is normally rampant in winter—but the pandemic has changed the behavior of this common and potentially dangerous infection. For National RSV Awareness Month, learn how Johnson & Johnson is working to keep us all safer from RSV.
-
In addition to its own cadre of scientists hard at work fighting the pandemic, Johnson & Johnson also supports external researchers and entrepreneurs equally dedicated to finding solutions for the current health crisis. We take a look at some of this groundbreaking work happening across the globe—from San Francisco to Seoul.
-
It's a lofty goal: improve the health, across the board, of future generations. But it's a mission that Johnson & Johnson is committed to. And thanks to groundbreaking work taking place across the company—from vaccine development to consumer product innovation—the future is looking very bright.
-
Bringing your passion to work has taken on new meaning for these inspiring Johnson & Johnson researchers.
-
These up-and-coming stars in oncology, immunology, anti-aging, vaccines and other areas of research are helping to change healthcare as we know it. And they're just at the beginning of their brilliant careers.
-
Sixty-four million people contract RSV each year—yet most people have never even heard of it. As peak infection season approaches, here’s a handy primer on respiratory syncytial virus.
